The Leicester Cough Questionnaire in two phase 3 trials of gefapixant in chronic cough

S. Birring (London, United Kingdom), J. Smith (University of MancManchester, United Kingdom), A. Morice (Cottingham, United Kingdom), I. Pavord (Oxford, United Kingdom), P. Dicpinigaitis (Bronx, United States of America), L. Mcgarvey (Belfast, United Kingdom), A. Tzontcheva (Kenilworth, United States of America), Q. Li (Kenilworth, United States of America), A. Martin Nguyen (Kenilworth, United States of America), J. Schelfhout (Kenilworth, United States of America), D. Muccino (Kenilworth, United States of America), C. La Rosa (Kenilworth, United States of America)

Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Birring (London, United Kingdom), J. Smith (University of MancManchester, United Kingdom), A. Morice (Cottingham, United Kingdom), I. Pavord (Oxford, United Kingdom), P. Dicpinigaitis (Bronx, United States of America), L. Mcgarvey (Belfast, United Kingdom), A. Tzontcheva (Kenilworth, United States of America), Q. Li (Kenilworth, United States of America), A. Martin Nguyen (Kenilworth, United States of America), J. Schelfhout (Kenilworth, United States of America), D. Muccino (Kenilworth, United States of America), C. La Rosa (Kenilworth, United States of America). The Leicester Cough Questionnaire in two phase 3 trials of gefapixant in chronic cough. 1587

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010

The Cough Severity Diary in a pooled analysis of two, phase 3 trials of gefapixant in chronic cough
Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2
Year: 2021



The Leicester Cough Monitor: preliminary validation of an automated cough detection system in chronic cough
Source: Eur Respir J 2008; 31: 1013-1018
Year: 2008



Defining health states with visual analogue scale and Leicester Cough Questionnaire in chronic cough
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021


Translation, validity and reliability of the Leicester cough questionnaire into Swedish in COPD
Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient
Year: 2016


Symptom management: dyspnoea and cough
Source: Eur Respir Monogr 2016; 71: 218-229
Year: 2016


Evaluation of vocal performance questionnaire in people with chronic refractory cough
Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations
Year: 2013


The assessment of cough severity with the Leicester cough monitor
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009

Assessment of cough frequency to inhaled mannitol using ambulatory acoustic cough recording
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Chronic cough and asthma-like symptoms – Not always asthma
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2009; 34: 125-131
Year: 2009



Concurrent validation of a Dutch translation of the Leicester Cough Questionnaire
Source: Eur Respir J 2005; 26: Suppl. 49, 301s
Year: 2005

Reliability and validity of a Turkish version of Leicester cough questionnaire
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Repercussion of cough in sleep quality in COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


Assessment of symptoms: Cough reflex and LAR
Source: Research Seminar 2013 - Translational animal models of asthma
Year: 2013


Validity of questions used to assess chronic cough in epidemiological surveys
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013

Validation of a Spanish version of the Leicester cough questionnaire in adult patients with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013


Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014